Literature DB >> 32656230

Small Molecules and Biologics in the Treatment of Nail Psoriasis.

Dimitrios Rigopoulos1, Anna Stathopoulou1, Stamatios Gregoriou1.   

Abstract

Nail psoriasis (PsO) is a disorder with profound impact on patients' quality of life. Several challenges and unmet needs remain in the treatment of nail PsO. Introduction of biologics and small molecules in the treatment of nail PsO has allowed for rapid control of the disease and high efficacy. The aim of this review was to present the published studies on nail PsO therapy with biologics and small molecules and illuminate the results in the studies where the design and outcome evaluation had nail PsO in the forefront.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Adalimumab; Apremilast; Brodalumab; Guselkumab; Ixekizumab; Secukinumab

Year:  2020        PMID: 32656230      PMCID: PMC7325203          DOI: 10.1159/000507298

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  51 in total

1.  Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2/3 clinical trial.

Authors:  Atsuyuki Igarashi; Takeshi Kato; Mai Kato; Michael Song; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2011-09-29       Impact factor: 4.005

2.  Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.

Authors:  Peter Foley; Kenneth Gordon; Christopher E M Griffiths; Yasmine Wasfi; Bruce Randazzo; Michael Song; Shu Li; Yaung-Kaung Shen; Andrew Blauvelt
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

3.  Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.

Authors:  D Thaçi; K Unnebrink; M Sundaram; S Sood; Y Yamaguchi
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-05-21       Impact factor: 6.166

4.  Treatment and management of psoriasis with nail involvement: a focus on biologic therapy.

Authors:  Richard G Langley; Esteban Daudén
Journal:  Dermatology       Date:  2010-08-09       Impact factor: 5.366

5.  Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study.

Authors:  Aikaterini Kyriakou; Aikaterini Patsatsi; Dimitrios Sotiriadis
Journal:  J Dermatolog Treat       Date:  2012-01-04       Impact factor: 3.359

6.  A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.

Authors:  J P Ortonne; C Paul; E Berardesca; V Marino; G Gallo; Y Brault; J M Germain
Journal:  Br J Dermatol       Date:  2013-05       Impact factor: 9.302

7.  Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.

Authors:  Phoebe Rich; Richard K Scher
Journal:  J Am Acad Dermatol       Date:  2003-08       Impact factor: 11.527

8.  Treatment of nail psoriasis with adalimumab: an open label unblinded study.

Authors:  D Rigopoulos; S Gregoriou; E Lazaridou; E Belyayeva; Z Apalla; M Makris; A Katsambas; D Ioannides
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-10-06       Impact factor: 6.166

9.  Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.

Authors:  Phoebe Rich; Christopher E M Griffiths; Kristian Reich; Frank O Nestle; Richard K Scher; Shu Li; Stephen Xu; Ming-Chun Hsu; Cynthia Guzzo
Journal:  J Am Acad Dermatol       Date:  2007-12-20       Impact factor: 11.527

10.  Distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis.

Authors:  Magdalena Krajewska-Włodarczyk; Agnieszka Owczarczyk-Saczonek; Waldemar Placek; Maja Wojtkiewicz; Andrzej Wiktorowicz; Joanna Wojtkiewicz
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

View more
  1 in total

Review 1.  Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.

Authors:  Alan Menter; Tina Bhutani; Benjamin Ehst; Boni Elewski; Abby Jacobson
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.